Verified Nov 2026
Diversified Tier 1
·

Cortlandt Manor, New York
·
Since 1980
Polymedco is a healthcare company based in Cortlandt Manor, New York, founded in 1980 and reported to employ between 100 and 200 people, with an estimated revenue band of $10-50 million. The company develops in vitro diagnostic tests for early disease detection and screening, serving the medical sector along with automotive, electric-vehicle, and industrial-equipment markets. Its Fecal Immunochemical Test (OC-Auto FIT) is used for colorectal cancer screening, and in January 2025 the company reported that the product was playing a role in the U.S. Department of Veterans Affairs' National Colorectal Cancer Screening Program. The company is privately held.
Polymedco at a glance
Revenue
$10-50M
Est. band
Employees
100-200
Founded
1980
Headquarters
Cortlandt Manor, New York
Import activity
126
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
126
Named foreign suppliers
4
Top origins
Italy · China · South Korea

Shared foreign counterparties do not establish that these companies buy from Polymedco.
What this tells a buyer
No customs data is available for this company, and the most recent reported development is its April 2026 sponsorship of the Texas Association of Freestanding Emergency Centers, where it demonstrated its PATHFAST high-sensitivity cardiac troponin I test.
Its product line includes the OC-Auto FIT colorectal cancer screening test, the PATHFAST high-sensitivity cardiac troponin I test, the Sediplast Autozero Westergren ESR System, and the PATHFAST D-Dimer reagent, and no certifications are listed in the record.
The company is privately held and is estimated to have 100-200 employees, with revenue reported in an estimated band of $10-50 million.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
Overview
Polymedco is a healthcare company based in Cortlandt Manor, New York, founded in 1980 and reported to employ between 100 and 200 people, with an estimated revenue band of $10-50 million. The company develops in vitro diagnostic tests for early disease detection and screening, serving the medical sector along with automotive, electric-vehicle, and industrial-equipment markets. Its Fecal Immunochemical Test (OC-Auto FIT) is used for colorectal cancer screening, and in January 2025 the company reported that the product was playing a role in the U.S. Department of Veterans Affairs' National Colorectal Cancer Screening Program. The company is privately held.
At a glance
Attribute | Detail |
|---|---|
Founded | 1980 |
Headquarters | Cortlandt Manor, New York |
Employees | 100-200 |
Revenue | $10-50M (estimated) |
Primary capability | Diversified Tier 1 |
What Polymedco makes
Its product line includes the OC-Auto FIT colorectal cancer screening test, the PATHFAST high-sensitivity cardiac troponin I test, the Sediplast Autozero Westergren ESR System, and the PATHFAST D-Dimer reagent, and no certifications are listed in the record.
Trade and customs footprint
No customs data is available for this company, and the most recent reported development is its April 2026 sponsorship of the Texas Association of Freestanding Emergency Centers, where it demonstrated its PATHFAST high-sensitivity cardiac troponin I test. US customs bill-of-lading records list 126 inbound shipments across 4 foreign suppliers, with top origins including Italy · China · South Korea.
Latest developments
2026-04-28 — We are happy to announce a new Capitol sponsor, Polymedco. Polymedco joined us for our member meeting last week to demonstrate their high sensitivity cardiac troponin l test, PATHFAST, to aid in … | Texas Association of Freestanding Emergency Centers (linkedin.com)
2026-04-15 — SAM.gov (sam.gov)
2025-06-17 — After a brief hiatus from the med device industry, I’m excited to share I’ve joined Polymedco as Director of Production. Polymedco is a leading provider of screening / early detection solutions. | Jon Lang (linkedin.com)
2025-02-20 — Polymedco Announces: New Published Research Supports Fecal Immunochemical Testing (FIT) as the Most Clinically and Cost Effective Noninvasive Colorectal Cancer Screening (CRC) method (prnewswire.com)
2025-01-28 — Polymedco is proud to support The Cancer Moonshot Program by having OC-Auto FIT play a role in one of its newest initiatives: The VA’s National Colorectal Cancer Screening Program. With mail-in FIT … (linkedin.com)
Company details
The company is privately held and is estimated to have 100-200 employees, with revenue reported in an estimated band of $10-50 million. Polymedco was founded in 1980, has an estimated 100-200 employees, and is headquartered in Cortlandt Manor, New York.
Frequently asked questions
What does Polymedco make?
Polymedco is a healthcare company based in Cortlandt Manor, New York, founded in 1980 and reported to employ between 100 and 200 people, with an estimated revenue band of $10-50 million. The company develops in vitro diagnostic tests for early disease detection and screening, serving the medical sector along with automotive, electric-vehicle, and industrial-equipment markets. Its Fecal Immunochemical Test (OC-Auto FIT) is used for colorectal cancer screening, and in January 2025 the company reported that the product was playing a role in the U.S. Department of Veterans Affairs' National Colorectal Cancer Screening Program. The company is privately held.
Where is Polymedco headquartered?
Polymedco is headquartered in Cortlandt Manor, New York (510 Furnace Dock Rd, Cortlandt Manor, New York, 10567).
When was Polymedco founded?
Polymedco was founded in 1980.
How big is Polymedco?
Polymedco has an estimated 100-200 employees, with revenue in the $10-50M range (estimated).
Does Polymedco import from overseas suppliers?
US customs bill-of-lading records show 126 inbound shipments for Polymedco, with top origins including Italy · China · South Korea.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
